Research Article
Matrix Metalloproteinase-9: Its Interplay with Angiogenic Factors in Inflammatory Bowel Diseases
Table 1
Characteristics of study population.
| | Index | Controls | UC | CD | | All | UCa | UCi | All | CDa | CDi |
| | MMP-9 [ng/mL] |
1.91 (0.83–3.03) | 5.02 (3.22–7.68) | 11.93 (5.2–22.0) | 2.99 (1.76–4.36) | 3.47 (2.12–4.08) | 4.61 (3.48–7.96) | 1.22 (0.61–3.12) | | CRP [mg/L] | 3.7 (1.8–4.0) | 18.8 (10.4–31.9) | 44.5 (21.0–109.7) | 9.5 (3.2–14.3) | 25.1 (12.8–57.1) | 67.3 (30.5–111.0) | 17.3 (2.4–32.1) | | CDAI | — | — | — | — | 160 (129–205) | 227 (186–259) | 94 (52–114) | | CAI | — | 3 (2–4) | 5 (4–7) | 1 (0–2) | — | — | — | | ESR [mm/h] | ND | 16 (12–27) | 36.5 (17–50) | 11.5 (8–19) | 20 (16–26) | 31 (20–42) | 13 (10–17) | | HGB [g/dL] | ND | 12.8 (12.1–13.5) | 11.7 (10.4–12.6) | 13.5 (12.8–14.0) | 12.2 (11.7–13.0) | 11.7 (10.9–12.4) | 13.0 (12.2–13.9) | | PLT [/L] | ND | 299 (277–324) | 349 (304–416) | 273 (252–292) | 345 (253–397) | 389 (334–464) | 247 (208–370) | | WBC [/L] | ND | 7.3 (6.2–8.1) | 8.4 (6.6–9.9) | 6.6 (6.0–7.4) | 6.8 (5.7–8.2) | 7.7 (5.6–8.8) | 6.2 (5.2–7.9) |
|
|
If not otherwise stated, data are presented as medians with 95% CI around median; CD: Crohn’s disease; CDa: active Crohn’s disease; CDi: inactive Crohn’s disease; UC: ulcerative colitis; UCa: active ulcerative colitis; UCi: inactive ulcerative colitis; M/F: males/females ratio; CRP: C-reactive protein; CDAI: Crohn’s disease activity index; CAI: clinical activity index; ESR: erythrocyte sedimentation rate; HGB: haemoglobin; PLT: platelet count; WBC: white blood cell count, ND: no data.
|
